(2S)-N-((1S)-1-CYANO-2-(2-FLUORO-4-(1-METHYL-1H-INDAZOL-6-YL)PHENYL)ETHYL)HEXAHYDRO-1,4-OXAZEPINE-2-CARBOXAMIDE
UNII S9A9SVQ333
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s)-n-((1s)-1-cyano-2-(2-fluoro-4-(1-methyl-1h-indazol-6-yl)phenyl)ethyl)hexahydro-1,4-oxazepine-2-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9A9SVQ333.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2813250-38-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H24FN5O2 IVFUIEQQJAEOCC-UGKGYDQZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s)-n-((1s)-1-cyano-2-(2-fluoro-4-(1-methyl-1h-indazol-6-yl)phenyl)ethyl)hexahydro-1,4-oxazepine-2-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.